Company news
Virogates A/s (OMXCOP:VIRO) news
Virogates A/s news releases on 6ix. Latest, Aug 13, 2026: ViroGates announces revised financial guidance for 2026
Press releases & updates
ViroGates announces revised financial guidance for 2026
August 13, 2026
ViroGates announces its Interim Report for Q1-2026
May 7, 2026
Resolutions from the Annual General Meeting of ViroGates A/S
April 23, 2026
ViroGates submits its De Novo application to the U.S. FDA for suPARnostic® TurbiLatex
April 8, 2026
ViroGates gives notice to convene the Annual General Meeting on 23 April 2026
April 8, 2026
ViroGates announces its Annual Report 2025: Revenue growth and improved operating result as strategic transition towards preventive health and longevity continues
March 26, 2026
ViroGates publishes its financial calendar for 2026
December 12, 2025
ViroGates announces financial guidance for 2026
December 12, 2025
ViroGates’ capital raise of DKK 19.3 million and issue of 1,547,412 shares have been registered and settled
November 28, 2025
ViroGates announces a directed issue of nominally 1,547,412 shares, raising approximately DKK 19.3 million
November 18, 2025
ViroGates announces a plan to offer new shares through a directed issue without preemptive rights for existing shareholders
November 17, 2025
ViroGates announces its Interim Report for Q1-Q3 2025
November 6, 2025
ViroGates announces Notice of Potential Equity / Capital Raise
October 23, 2025
ViroGates Receives FDA Feedback on 513(g) Request, confirming Regulatory Pathway for U.S. Market Entry
October 17, 2025
Nextech3D.ai Partners with Vertical Insure to Offer Embedded Event Insurance Through Map Dynamics
September 3, 2025
ViroGates announces its Half-Year Report for H1 2025
August 21, 2025
Resolutions from the Extraordinary General Meeting of ViroGates A/S
May 21, 2025